Plasmacytoma

hematologic malignancy

Identifier: CI-CAN-00001423
Entity page: /cancer/plasmacytoma ↗
Edges: 64

Neighbours: 23 drugs10 trials
Drawn: 33 of 33 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Plasmacytoma investigated for …INVESTIGATED_FOR15 of 15
← investigated for	Zoledronic Acidsmall_molecule	unknown	3	Plasmacytoma	1	Curated	chembl	graph →
← investigated for	Lenalidomidesmall_molecule	unknown	3

Plasmacytoma investigated in trials for …INVESTIGATED_IN_TRIALSderived21 of 21show fewer
→ investigated in trials for	Dexamethasonesmall_molecule 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall_molecule 6 trials (4 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall_molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall_molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ixazomibsmall_molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall_molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Busulfansmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carfilzomibother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Daratumumabmonoclonal_antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Methotrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Navtemadlinsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Panobinostatsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pomalidomidesmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →

Plasmacytoma investigated in trials for …INVESTIGATED_IN_TRIALSderived21 of 21show fewer

→ investigated in trials for

Dexamethasonesmall_molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Plasmacytoma

Observed

Plasmacytoma studied in …STUDIED_INderived10 of 28show all (up to 200)
→ studied in	NCT06429150Phase 1/Phase 2 · not yet recruiting Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (7 active)	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04166565Phase 2 · active not recruiting Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease · condition mapped ALIAS · 28 trials mapped (7 active)	—	—	Extraosseous Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03031730Phase 1 · terminated Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (7 active)	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 28 trials mapped (7 active)	—	—	Extraosseous Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04174196Phase 2 · active not recruiting A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (7 active)	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02506959Phase 2 · completed Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (7 active)	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06863584Phase 2 · recruiting SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial · condition mapped ONTOLOGY_EXACT · 28 trials mapped (7 active)	—	—	Solitary Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02921893early Phase 1 · completed Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome · condition mapped ONTOLOGY_EXACT · 28 trials mapped (7 active)	—	—	Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05260203NA · completed MargheRITA (Remote Intelligence for Therapeutic Adherence) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (7 active)	—	—	Solitary Plasmacytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05248633Phase 2 · recruiting Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (7 active)	—	—	Solitary Plasmacytoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains